These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 29052581)
1. Corrigendum: Efficacy of Real world Entecavir Therapy in Treatment NaïveChronic Hepatitis B Patients. Chin Med J (Engl); 2017 Oct; 130(20):2520. PubMed ID: 29052581 [TBL] [Abstract][Full Text] [Related]
2. Corrigendum to "Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients". Ji LS; Gao QT; Guo RW; Zhang X; Zhou ZH; Yu Z; Zhu X; Gao YT; Sun XH; Gao YQ; Li M J Immunol Res; 2022; 2022():7931597. PubMed ID: 35127955 [TBL] [Abstract][Full Text] [Related]
3. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice. Tsai MC; Lee CM; Chiu KW; Hung CH; Tung WC; Chen CH; Tseng PL; Chang KC; Wang JH; Lu SN; Yen YH; Hu TH J Antimicrob Chemother; 2012 Mar; 67(3):696-9. PubMed ID: 22174039 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients. Suzuki F; Toyoda J; Katano Y; Sata M; Moriyama M; Imazeki F; Kage M; Seriu T; Omata M; Kumada H J Gastroenterol Hepatol; 2008 Sep; 23(9):1320-6. PubMed ID: 18554238 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma. Riveiro-Barciela M; Tabernero D; Calleja JL; Lens S; Manzano ML; Rodríguez FG; Crespo J; Piqueras B; Pascasio JM; Comas C; Gutierrez ML; Aguirre A; Suárez E; García-Samaniego J; Rivero M; Acero D; Fernandez-Bermejo M; Moreno D; Sánchez-Pobre P; de Cuenca B; Moreno-Palomares JJ; Esteban R; Buti M Dig Dis Sci; 2017 Mar; 62(3):784-793. PubMed ID: 28078526 [TBL] [Abstract][Full Text] [Related]
7. Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program. Yuan Y; Iloeje U; Li H; Hay J; Yao GB Value Health; 2008 Mar; 11 Suppl 1():S11-22. PubMed ID: 18387054 [TBL] [Abstract][Full Text] [Related]
8. Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B. Rivkin A Drugs Today (Barc); 2007 Apr; 43(4):201-20. PubMed ID: 17460784 [TBL] [Abstract][Full Text] [Related]
9. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial. Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance? Suzuki Y; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Miyakawa Y; Kumada H J Gastroenterol Hepatol; 2009 Mar; 24(3):429-35. PubMed ID: 19226381 [TBL] [Abstract][Full Text] [Related]
11. Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment. Li GJ; Yu YQ; Chen SL; Fan P; Shao LY; Chen JZ; Li CS; Yi B; Chen WC; Xie SY; Mao XN; Zou HH; Zhang WH Antimicrob Agents Chemother; 2015 Jul; 59(7):4121-8. PubMed ID: 25941216 [TBL] [Abstract][Full Text] [Related]
12. Head-To-Head Comparison of Two Years Efficacy of Entecavir and Tenofovir in Patients with Treatment-Naïve Chronic Hepatitis B--The Real Life Data. Hepatogastroenterology; 2015 Jun; 62(140):982-6. PubMed ID: 26902041 [TBL] [Abstract][Full Text] [Related]
13. Entecavir monotherapy for lamivudine-refractory chronic hepatitis B. Goulis I; Dalekos GN Expert Rev Anti Infect Ther; 2008 Dec; 6(6):855-9. PubMed ID: 19053898 [TBL] [Abstract][Full Text] [Related]
14. Entecavir for the treatment of chronic hepatitis B virus infection. Matthews SJ Clin Ther; 2006 Feb; 28(2):184-203. PubMed ID: 16678641 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study. Liaw YF; Raptopoulou-Gigi M; Cheinquer H; Sarin SK; Tanwandee T; Leung N; Peng CY; Myers RP; Brown RS; Jeffers L; Tsai N; Bialkowska J; Tang S; Beebe S; Cooney E Hepatology; 2011 Jul; 54(1):91-100. PubMed ID: 21503940 [TBL] [Abstract][Full Text] [Related]
16. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience. Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419 [TBL] [Abstract][Full Text] [Related]
17. [Entecavir in the treatment of chronic hepatitis B: multicenter randomized trials and real clinical practice]. Abdurakhmanov DT; Otrashevskaya AV Ter Arkh; 2014; 86(11):100-4. PubMed ID: 25715497 [TBL] [Abstract][Full Text] [Related]
18. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting. Idilman R; Gunsar F; Koruk M; Keskin O; Meral CE; Gulsen M; Elhan AH; Akarca US; Yurdaydin C J Viral Hepat; 2015 May; 22(5):504-10. PubMed ID: 25431108 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir. Choi HN; Song JE; Lee HC; Jo HH; Lee CH; Kim BS Clin Mol Hepatol; 2015 Mar; 21(1):24-31. PubMed ID: 25834799 [TBL] [Abstract][Full Text] [Related]
20. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients. Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]